Processing

Please wait...

Settings

Settings

Goto Application

1. EP3127908 - PROCESS FOR PREPARING COMPOUND HAVING HIV INTEGRASE INHIBITORY ACTIVITY

Office
European Patent Office
Application Number 16190894
Application Date 04.08.2011
Publication Number 3127908
Publication Date 08.02.2017
Publication Kind B1
IPC
C07D 498/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
12in which the condensed system contains three hetero rings
14Ortho-condensed systems
CPC
C07D 498/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
12in which the condensed system contains three hetero rings
14Ortho-condensed systems
C07D 213/79
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
213Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02having three double bonds between ring members or between ring members and non-ring members
04having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
60with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
78Carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals
79Acids; Esters
C07B 2200/13
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
2200Indexing scheme relating to specific properties of organic compounds
13Crystalline forms, e.g. polymorphs
A61K 31/5365
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5365ortho- or peri-condensed with heterocyclic ring systems
C07D 213/80
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
213Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02having three double bonds between ring members or between ring members and non-ring members
04having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
60with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
78Carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals
79Acids; Esters
80in position 3
C07D 211/94
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
211Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
92with a hetero atom directly attached to the ring nitrogen atom
94Oxygen atom, e.g. piperidine N-oxide
Applicants SHIONOGI & CO
Inventors SUMINO YUKIHITO
OKAMOTO KAZUYA
MASUI MORIYASU
YAMADA DAISUKE
IKARASHI FUMIYA
Designated States
Priority Data 11814690 04.08.2011 EP
2010175899 05.08.2010 JP
2010277713 14.12.2010 JP
Title
(DE) VERFAHREN ZUR HERSTELLUNG EINER VERBINDUNG MIT HIV-INTEGRASE-HEMMENDER WIRKUNG
(EN) PROCESS FOR PREPARING COMPOUND HAVING HIV INTEGRASE INHIBITORY ACTIVITY
(FR) PROCÉDÉ POUR PRÉPARER UN COMPOSÉ AYANT UNE ACTIVITÉ INHIBITRICE D'INTÉGRASE DE VIH
Abstract
(EN) A process for preparing a compound represented by formula (Y1) or (Y2) [wherein R x is an optionally substituted carbocyclyl lower alkyl, or the like] or a salt thereof, using a novel process for preparing a pyridone derivative represented by formula (X4) [wherein R 1d is hydrogen, halogen, or the like; R 2d is hydrogen, a lower alkyl optionally substituted with substituent E, or the like; R 4d is a lower alkyl optionally substituted with substituent E, or the like; and R 6d is a lower alkyl group optionally substituted with substituent group E].
(FR) La présente invention concerne un procédé pour préparer un composé représenté par la formule (Y1) ou (Y2) [dans lesquelles Rx est un groupe carbocyclyl-(alkyle inférieur) facultativement substitué, ou similaire], utilisant un nouveau processus pour préparer un dérivé de pyridone représenté par la formule (X4) [dans laquelle R1d est un hydrogène, un halogène, ou similaire; R2d est un hydrogène, un groupe alkyle inférieur, ou similaire, ledit groupe alkyle inférieur étant facultativement substitué par un ou plusieurs choisis parmi le groupe de substituant E; R4d est un groupe alkyle inférieur ou similaire, ledit groupe alkyle inférieur étant facultativement substitué par un ou plusieurs choisis parmi le groupe de substituant E; et R6d est un groupe alkyle inférieur ou similaire, ledit groupe alkyle inférieur étant facultativement substitué par un ou plusieurs choisis parmi un groupe substituant E].